...
首页> 外文期刊>Internal medicine. >Low-Density Lipoprotein Apheresis Therapy for Steroid- and Cyclosporine-Resistant Idiopathic Membranous Nephropathy
【24h】

Low-Density Lipoprotein Apheresis Therapy for Steroid- and Cyclosporine-Resistant Idiopathic Membranous Nephropathy

机译:类固醇和环孢菌素耐药性特发性膜性肾病的低密度脂蛋白置换疗法。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

We herein report three cases of Nephrotic Syndrome (NS) with idiopathic membranous nephropathy (IMN) in which the patients were resistant to steroid (PSL) and cyclosporine (CyA) therapy. All three patients had a high risk of renal failure because of persistently high levels of proteinuria. We performed low-density lipoprotein apheresis (LDL-A) and achieved complete remission in two cases. The third patients developed NS relapse and a deteriorating renal function; however, withdrawal from dialysis therapy was achieved. There are no proven therapies for treating patients with PSL- and CyA-resistant IMN with acute deteriorating renal function or difficulties in maintaining fluid balance. We evaluated the treatment course and physiological mechanisms and reviewed similar cases in the pertinent literature.
机译:我们在此报告三例患有特发性膜性肾病(IMN)的肾病综合征(NS),其中患者对类固醇(PSL)和环孢素(CyA)治疗有抗药性。由于持续高水平的蛋白尿,所有三名患者都有肾衰竭的高风险。我们进行了低密度脂蛋白血液分离术(LDL-A),并在两种情况下实现了完全缓解。第三例患者出现NS复发和肾功能恶化。然而,实现了从透析治疗中退出。目前尚无有效的疗法可治疗患有PSL和CyA耐药性IMN的肾功能急性恶化或难以维持体液平衡的患者。我们评估了治疗过程和生理机制,并复习了相关文献中的类似病例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号